Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

C T Holdings Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 1/6

C T Holdings şirketinin toplam hissedar öz sermayesi LKR43.2B ve toplam borcu LKR59.9B olup, bu da borç-öz sermaye oranını 138.8% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla LKR142.2B ve LKR99.1B dir. C T Holdings 'in FAVÖK'ü LKR13.5B faiz karşılama oranı 2.8 dur. Şirketin LKR8.4B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

138.8%

Borç/özkaynak oranı

LK₨59.94b

Borç

Faiz karşılama oranı	2.8x
Nakit	LK₨8.41b
Eşitlik	LK₨43.18b
Toplam yükümlülükler	LK₨99.05b
Toplam varlıklar	LK₨142.24b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: CTHR.N0000 'nin kısa vadeli varlıkları ( LKR44.1B ) kısa vadeli yükümlülüklerini ( LKR68.4B ) kapsamıyor.

Uzun Vadeli Yükümlülükler: CTHR.N0000 şirketinin kısa vadeli varlıkları ( LKR44.1B ) uzun vadeli yükümlülüklerini ( LKR30.6B ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: CTHR.N0000 'nin net borç/öz sermaye oranı ( 119.3% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: CTHR.N0000 şirketinin borç/öz sermaye oranı son 5 yılda 62.2% seviyesinden 138.8% seviyesine yükseldi.

Borç Kapsamı: CTHR.N0000 'nin borcu işletme nakit akışı ( 19.4% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: CTHR.N0000 'in borcuna ilişkin faiz ödemeleri EBIT ( 2.8 x kapsam) tarafından iyi karşılanmıyor.

C T Holdings Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 1/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

C T Holdings plc Announces board Committee Changes

First quarter 2025 earnings released: EPS: LK₨5.31 (vs LK₨3.77 in 1Q 2024)

Full year 2024 earnings released: EPS: LK₨21.63 (vs LK₨17.17 in FY 2023)

C T Holdings PLC, Annual General Meeting, Aug 01, 2024

Deputy Chairman & MD recently bought LK₨168k worth of stock

Deputy Chairman & MD recently bought LK₨2.7m worth of stock

Full year 2024 earnings released: EPS: LK₨21.62 (vs LK₨17.17 in FY 2023)

Non-Executive Director recently bought LK₨4.4m worth of stock

Dividend of LK₨8.50 announced

Non-Executive Director recently bought LK₨7.2m worth of stock

Third quarter 2024 earnings released: EPS: LK₨3.86 (vs LK₨2.30 in 3Q 2023)

Deputy Chairman & MD recently bought LK₨2.7m worth of stock

Non-Executive Director recently bought LK₨3.1m worth of stock

Second quarter 2024 earnings released: EPS: LK₨6.13 (vs LK₨3.74 in 2Q 2023)

Investor sentiment improves as stock rises 15%

First quarter 2024 earnings released: EPS: LK₨3.77 (vs LK₨4.66 in 1Q 2023)

Non-Executive Director recently bought LK₨2.0m worth of stock

Full year 2023 earnings released: EPS: LK₨17.17 (vs LK₨14.09 in FY 2022)

C T Holdings PLC, Annual General Meeting, Jul 28, 2023

Deputy Chairman & MD recently bought LK₨133m worth of stock

Full year 2023 earnings released: EPS: LK₨17.17 (vs LK₨14.09 in FY 2022)

Non-Independent Non-Executive Director recently bought LK₨9.4m worth of stock

Non-Independent Non-Executive Director recently bought LK₨17m worth of stock

Non-Independent Non-Executive Director recently bought LK₨1.8m worth of stock

Deputy Chairman & MD recently bought LK₨5.4m worth of stock

Third quarter 2023 earnings released: EPS: LK₨2.30 (vs LK₨4.31 in 3Q 2022)

Non-Independent Non-Executive Director recently bought LK₨165k worth of stock

Insufficient new directors

Second quarter 2023 earnings released

Non-Independent Non-Executive Director recently bought LK₨170k worth of stock

Non-Independent Non-Executive Director recently bought LK₨890k worth of stock

Deputy Chairman & MD recently bought LK₨21m worth of stock

Deputy Chairman & MD recently bought LK₨2.7m worth of stock

First quarter 2023 earnings released: EPS: LK₨4.66 (vs LK₨1.39 in 1Q 2022)

Upcoming dividend of LK₨3.00 per share

Full year 2022 earnings released: EPS: LK₨14.09 (vs LK₨10.24 in FY 2021)

C T Holdings PLC, Annual General Meeting, Jul 29, 2022

Deputy Chairman & MD recently bought LK₨67m worth of stock

Full year 2022 earnings released: EPS: LK₨14.18 (vs LK₨10.24 in FY 2021)

Insufficient new directors

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Deputy Chairman & MD recently bought LK₨3.3m worth of stock

Deputy Chairman & MD recently bought LK₨10.0m worth of stock

Non-Executive Director recently bought LK₨2.5m worth of stock

Non-Executive Director recently bought LK₨2.5m worth of stock

Non-Executive Director recently bought LK₨3.5m worth of stock

Upcoming dividend of LK₨1.55 per share

Second quarter 2022 earnings released: EPS LK₨2.12 (vs LK₨1.66 in 2Q 2021)

Non-Executive Director recently bought LK₨1.6m worth of stock

Non-Executive Director recently bought LK₨917k worth of stock

Non-Executive Director recently bought LK₨966k worth of stock

First quarter 2022 earnings released: EPS LK₨1.39 (vs LK₨0.06 loss in 1Q 2021)

Deputy Chairman & MD recently bought LK₨3.3m worth of stock

Deputy Chairman & MD recently bought LK₨36m worth of stock

Independent Non-Executive Director Sunil Mendis has left the company

Non-Executive Director recently bought LK₨936k worth of stock

Upcoming dividend of LK₨2.90 per share

Non-Executive Director recently bought LK₨675k worth of stock

Deputy Chairman & MD recently bought LK₨35m worth of stock

Third quarter 2021 earnings released: EPS LK₨2.14 (vs LK₨1.84 in 3Q 2020)

New 90-day high: LK₨182

Deputy Chairman & MD recently bought LK₨49m worth of stock

Deputy Chairman & MD recently bought LK₨2.9m worth of stock

Non-Executive Director recently bought LK₨141k worth of stock

New 90-day high: LK₨179

Second quarter 2021 earnings released: EPS LK₨1.66

Deputy Chairman & MD recently bought LK₨9.2m worth of stock

New 90-day high: LK₨170

Deputy Chairman & MD recently bought LK₨46m worth of stock

New 90-day high: LK₨165

First quarter earnings released

Full year earnings released - EPS LK₨8.32

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço